This article was written by Follow As an investor who started my path five years ago…
Tag: Hims
Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS)
This article was written by Follow Stone Fox Capital (aka Mark Holder) is a CPA with…
Don’t Buy Hims & Hers Stock If You Want Better Than Mediocre Returns (NYSE:HIMS)
This article was written by Follow Oliver Rodzianko is an investment analyst specializing in the technology…
Hims & Hers Health’s chief commercial officer sells $50,594 in stock By Investing.com
Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently sold shares…
Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It Lasted
Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It…
Hims & Hers CEO Andrew Dudum sells shares worth $6.24 million By Investing.com
SAN FRANCISCO—Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently reported…